Pipeline

Dystrogen Therapeutics is focused on the development of Cell Therapy Platform.

Candidates developed under Chimeric Cell platform:

• DEC - Duchenne Muscular Dystrophy Therapy
• Trimera - Sarcopenia
• DYST 101 - Anti-Aging